(S (NP-SBJ (NP (JJ Transgenic) (NN expression)) (PP (IN of) (NP (NN (RARalpha PML))))) (VP (VBZ impairs) (NP (NN myelopoiesis))) (. .))
(S (NP-SBJ (NP (DT The) (NN translocation)) (VP (VBN found) (NP (-NONE- *)) (PP (IN in) (NP (JJ acute) (JJ promyelocytic) (NN leukemia))))) (VP (VBZ rearranges) (NP (NP (NP (DT the) (JJ promyelocytic) (NN leukemia) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN PML)) (-RRB- -RRB-))) (PP (IN on) (NP (NN chromosome) (CD 15)))) (PP (IN with) (NP (NP (NP (DT the) (JJ retinoic) (NN acid) (NN receptor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN RARalpha)) (-RRB- -RRB-))) (PP (IN on) (NP (NN chromosome) (CD 17)))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBZ yields) (NP (NP (DT a) (NN fusion) (NN transcript)) (, ,) (NP (NN (RARalpha PML))) (, ,) (NP (NP (DT a) (NN transcription) (NN factor)) (PP (IN with) (NP (NP (VBN reported) (JJ dominant) (JJ negative) (NNS functions)) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN hormone)))))))) (. .))
(S (NP-SBJ-44 (NP (JJ Clinical) (NNS remissions)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN with) (NP (JJ all-trans) (NP (NP (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (NN treatment))) (PP (IN in) (NP (JJ acute) (JJ promyelocytic) (NN leukemia))))) (VP (VBP are) (VP (VBN linked) (NP (-NONE- *-44)) (PP (TO to) (NP (NP (NN (RARalpha PML)) (NN expression)) (PP (IN in) (NP (JJ leukemic) (NNS cells))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN (RARalpha PML)) (NN role)) (PP (IN in) (NP (NN myelopoiesis))))))) (, ,) (NP-SBJ-45 (NP (JJ transgenic) (NNS mice)) (VP (VBG expressing) (NP (NN (RARalpha PML))))) (VP (VBD were) (VP (VBN engineered) (NP (-NONE- *-45)))) (. .))
(S (NP-SBJ-46 (NP (DT A) (JJ full-length) (NN (RARalpha PML)) (NN cDNA)) (VP (VBN driven) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN CD11b) (NN promoter))))) (VP (VBD was) (VP (VBN expressed) (NP (-NONE- *-46)) (PP (IN in) (NP (JJ transgenic) (NNS mice))))) (. .))
(S (NP-SBJ-47 (NN Expression)) (VP (VBD was) (VP (VBN confirmed) (NP (-NONE- *-47)) (PP (IN in) (NP (DT the) (NN bone) (NN marrow))) (PP (IN with) (NP (DT a) (JJ reverse) (NN transcription) (NN PCR) (NN assay))))) (. .))
(S (NP-SBJ (JJ Basal) (JJ total) (NP-COOD (NP (JJ white) (NN blood) (NN cell)) (CC and) (NP (NN granulocyte))) (NNS counts)) (VP (VBD did) (RB not) (ADVP (RB appreciably)) (VP (VB differ) (PP (IN between) (NP (UCP-COOD (ADJP (NN (RARalpha PML)) (JJ transgenic)) (CC and) (NP (NN control))) (NNS mice))))) (. .))
(S (NP-SBJ (NP (NN Cell) (NN sorter) (NN analysis)) (PP (IN of) (NP (JJ CD11b+) (NN bone) (NN marrow) (NNS cells)))) (VP (VBD revealed) (NP (JJ similar) (JJ CD11b+) (NNS populations)) (PP (IN in) (NP (UCP-COOD (ADJP (JJ transgenic)) (CC and) (NP (NN control))) (NNS mice)))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (ADJP (FW in) (FW vitro)) (JJ clonal) (NN growth) (NNS assays)) (VP (VBN performed) (NP (-NONE- *)) (PP (IN on) (NP (NP (JJ peripheral) (NN blood)) (PP (IN from) (NP (UCP-COOD (ADJP (JJ transgenic)) (CC versus) (NP (NN control))) (NNS mice))))))) (VP (VBD revealed) (NP (NP (DT a) (JJ marked) (NN reduction)) (PP (IN of) (NP (JJ myeloid) (NNS progenitors))) (, ,) (PP (RB especially) (IN in) (NP (NP (DT those)) (VP (VBG responding) (PP (TO to) (NP (NN (macrophage granulocyte)) (JJ colony-stimulating) (NN factor)))))))) (. .))
(S (NP-SBJ-COOD (NP (NN (macrophage Granulocyte)) (JJ colony-stimulating) (NN factor)) (CC and) (NP (NN kit) (NN ligand) (NN cotreatment))) (VP (VBD did) (RB not) (VP (VB overcome) (NP (DT this) (NN inhibition)))) (. .))
(S (NP-SBJ-48 (NP (JJ Impaired) (NN myelopoiesis)) (ADVP (FW in) (FW vivo))) (VP (VBD was) (VP (VBN shown) (NP (-NONE- *-48)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG stressing) (NP (DT these) (NNS mice)) (PP (IN with) (NP (JJ sublethal) (NN irradiation)))))))) (. .))
(S (PP-TMP (VBG Following) (NP (NN irradiation))) (, ,) (NP-SBJ-49 (ADJP (NN (RARalpha PML)) (JJ transgenic)) (NNS mice)) (, ,) (SBAR (IN as) (S (NP-SBJ-50 (-NONE- *-49)) (VP (VBN compared) (NP (-NONE- *-50)) (PP (IN with) (NP (NNS controls)))))) (, ,) (ADVP-TMP (RBR more) (RB rapidly)) (VP (VBD depressed) (NP (NP-COOD (NP (JJ peripheral) (JJ white) (NN blood) (NN cell)) (CC and) (NP (NN granulocyte))) (NNS counts))) (. .))
(S (SBAR (IN As) (S (NP-SBJ-51 (-NONE- *)) (VP (VBN expected) (NP (-NONE- *-51))))) (, ,) (S-COOD (S (NP-SBJ (NP (QP (RB nearly) (DT all)) (NN control) (NNS mice)) (PRN (-LRB- -LRB-) (NP (CD 94.4) (NN %)) (-RRB- -RRB-))) (VP (VBD survived) (NP (NN irradiation)))) (, ,) (CC yet) (S (NP-SBJ (DT this) (NN irradiation)) (VP (VBD was) (ADJP-PRD (JJ lethal) (PP (TO to) (NP (NP (CD 45.8) (NN %)) (PP (IN of) (NP (ADJP (NN (RARalpha PML)) (JJ transgenic)) (NNS mice))))))))) (. .))
(S (NP-SBJ-52 (NN Lethality)) (VP (VBD was) (VP (VBN associated) (NP (-NONE- *-52)) (PP (IN with) (NP (ADJP (RBR more) (JJ severe)) (NN leukopenia))) (PP (IN in) (NP (UCP-COOD (ADJP (JJ transgenic)) (CC versus) (NP (NN control))) (NNS mice))))) (. .))
(S (NP-SBJ (NP (JJ Retinoic) (NN acid) (NN treatment)) (PP (IN of) (NP (JJ irradiated) (NN (RARalpha PML)) (NNS mice)))) (VP (VBD enhanced) (NP (NN granulocyte) (NN recovery))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (JJ abnormal) (NN myelopoiesis)) (PP (IN due) (TO to) (NP (NN (RARalpha PML)) (NN expression)))) (VP (VBZ is) (NP-PRD (NP (DT an) (JJ early) (NN event)) (PP (IN in) (NP (JJ oncogenic) (NN transformation)))))))) (. .))
